BJ
RETA

BlackRock Japan’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

BlackRock Japan’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-65
Closed -$1K – 1446
2016
Q2 		$1K Buy
+65
New +$1.26K ﹤0.01% 1411

Other funds holding RETA

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's RETA Position: Q3 2016 in Review

BlackRock Japan sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2016, closing a stake of 65 shares — an estimated $1K sold.

BlackRock Japan first reported a position in RETA in Q2 2016 and held it in 1 quarter. The position peaked at $1K in Q2 2016. 43 funds tracked by Wall St. Rank hold RETA as of Q3 2016.

  • BlackRock Japan reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2016 after selling out during the quarter.
  • BlackRock Japan sold 65 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2016, an estimated $1K.
  • BlackRock Japan first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2016 and held it in 1 quarter.
  • BlackRock Japan's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1K in Q2 2016.
  • 43 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2016.

Based on BlackRock Japan's 13F filing for Q3 2016, filed 8 Nov 2016.